New analysis unveiled today has uncovered vast variations in the care that men with prostate cancer receive across the whole of England. They reveal that many men in the West Midlands and Essex are receiving poor prostate cancer care and support whilst the majority of men living in Greater Manchester are getting what they need.

Read more

Dear Sir,

March is Prostate Cancer Awareness Month.  In a few weeks time NICE will meet to discuss the responses to their draft decision not to recommend abiraterone, a life extending drug for men with incurable prostate cancer.

Read more

We have criticised the Scottish Medicines Consortium's (SMC) decision not to recommend abiraterone for use on the NHS in Scotland. It follows the National Institute for Health and Clinical Excellence's (NICE) draft decision to deny the drug for men on the NHS in England and Wales.

Read more